|Articles|November 15, 2019
The Ins and Outs of Incorporating Patient Centricity in Drug Development
Author(s)Parexel
Related Content
Trending on PharmExec
1
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
2
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
3
What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?
4
How New Therapies are Tackling Unmet Needs in IBS
5